{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:49:33Z","timestamp":1791139773069,"version":"4.1.0"},"reference-count":108,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1681\/asn.2013111184","type":"journal-article","created":{"date-parts":[[2014,6,13]],"date-time":"2014-06-13T03:51:31Z","timestamp":1402631491000},"page":"2399-2418","source":"Crossref","is-referenced-by-count":148,"title":["Predictors of Autosomal Dominant Polycystic Kidney Disease Progression"],"prefix":"10.1681","volume":"25","author":[{"given":"Robert W.","family":"Schrier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Godela","family":"Brosnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Cadnapaphornchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Chonchol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Friend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berenice","family":"Gitomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230208","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","article-title":"Autosomal dominant polycystic kidney disease.","volume":"369","author":"Torres","year":"2007","journal-title":"Lancet"},{"key":"R2-7-20230208","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1016\/j.bbadis.2010.11.014","article-title":"Polycystic kidney disease: Pathogenesis and potential therapies.","volume":"1812","author":"Takiar","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"R4-7-20230208","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1056\/NEJMoa054341","article-title":"Volume progression in polycystic kidney disease.","volume":"354","author":"Grantham","year":"2006","journal-title":"N Engl J Med"},{"key":"R5-7-20230208","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD.","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R6-7-20230208","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1681\/ASN.V7102142","article-title":"Linkage, clinical features, and prognosis of autosomal dominant polycystic kidney disease types 1 and 2.","volume":"7","author":"Torra","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"R7-7-20230208","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1681\/ASN.V8101560","article-title":"Identification of patients with autosomal dominant polycystic kidney disease at highest risk for end-stage renal disease.","volume":"8","author":"Johnson","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R8-7-20230208","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(98)03495-3","article-title":"Comparison of phenotypes of polycystic kidney disease types 1 and 2.","volume":"353","author":"Hateboer","year":"1999","journal-title":"Lancet"},{"key":"R9-7-20230208","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2215\/CJN.01581105","article-title":"Incident renal events and risk factors in autosomal dominant polycystic kidney disease: A population and family-based cohort followed for 22 years.","volume":"1","author":"Dicks","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R10-7-20230208","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1681\/ASN.2006080835","article-title":"Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease.","volume":"17","author":"Harris","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R11-7-20230208","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00467-008-1090-9","article-title":"Genotype-phenotype correlation in children with autosomal dominant polycystic kidney disease.","volume":"24","author":"Fencl","year":"2009","journal-title":"Pediatr Nephrol"},{"key":"R12-7-20230208","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(03)13773-7","article-title":"Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype.","volume":"361","author":"Rossetti","year":"2003","journal-title":"Lancet"},{"key":"R13-7-20230208","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1046\/j.1523-1755.2000.00989.x","article-title":"Location of mutations within the PKD2 gene influences clinical outcome.","volume":"57","author":"Hateboer","year":"2000","journal-title":"Kidney Int"},{"key":"R14-7-20230208","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1097\/01.ASN.0000061774.90975.25","article-title":"Genotype-renal function correlation in type 2 autosomal dominant polycystic kidney disease.","volume":"14","author":"Magistroni","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R15-7-20230208","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/ki.2011.370","article-title":"A missense mutation in PKD1 attenuates the severity of renal disease.","volume":"81","author":"Pei","year":"2012","journal-title":"Kidney Int"},{"key":"R16-7-20230208","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"R17-7-20230208","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R18-7-20230208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1136\/jmedgenet-2011-100452","article-title":"Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.","volume":"49","author":"Losekoot","year":"2012","journal-title":"J Med Genet"},{"key":"R19-7-20230208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2369-14-59","article-title":"Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.","volume":"14","author":"Reiterov\u00e1","year":"2013","journal-title":"BMC Nephrol"},{"key":"R20-7-20230208","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1523-1755.2005.00203.x","article-title":"Modifier genes play a significant role in the phenotypic expression of PKD1.","volume":"67","author":"Fain","year":"2005","journal-title":"Kidney Int"},{"key":"R21-7-20230208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0272-6386(99)70355-0","article-title":"Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease.","volume":"34","author":"P\u00e9rez-Oller","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"R22-7-20230208","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfg292","article-title":"Influence of ACE (I\/D) and G460W polymorphism of \u03b1-adducin in autosomal dominant polycystic kidney disease.","volume":"18","author":"Persu","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"R23-7-20230208","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/hmg\/11.3.229","article-title":"Modifier effect of ENOS in autosomal dominant polycystic kidney disease.","volume":"11","author":"Persu","year":"2002","journal-title":"Hum Mol Genet"},{"key":"R24-7-20230208","doi-asserted-by":"crossref","first-page":"c169","DOI":"10.1159\/000116887","article-title":"A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.","volume":"108","author":"Zeltner","year":"2008","journal-title":"Nephron Clin Pract"},{"key":"R25-7-20230208","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2362.2007.01913.x","article-title":"Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: A potential modifier in autosomal dominant polycystic kidney disease.","volume":"38","author":"Dedoussis","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"R26-7-20230208","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1038\/ki.1992.195","article-title":"Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease.","volume":"41","author":"Gabow","year":"1992","journal-title":"Kidney Int"},{"key":"R27-7-20230208","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1681\/ASN.V661634","article-title":"Factors influencing progression of renal failure in autosomal dominant polycystic kidney disease.","volume":"6","author":"Choukroun","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R28-7-20230208","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1681\/ASN.V491670","article-title":"Autosomal dominant polycystic kidney disease in blacks: Clinical course and effects of sickle-cell hemoglobin.","volume":"4","author":"Yium","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R29-7-20230208","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1681\/ASN.V661643","article-title":"More adverse renal prognosis of autosomal dominant polycystic kidney disease in families with primary hypertension.","volume":"6","author":"Geberth","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R30-7-20230208","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1046\/j.1523-1755.2003.00264.x","article-title":"The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease.","volume":"64","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"key":"R31-7-20230208","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1681\/ASN.2009020162","article-title":"Family history of renal disease severity predicts the mutated gene in ADPKD.","volume":"20","author":"Barua","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"R32-7-20230208","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.2215\/CJN.01010211","article-title":"Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.","volume":"6","author":"Helal","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R33-7-20230208","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1681\/ASN.2006050500","article-title":"Oxidants in chronic kidney disease.","volume":"18","author":"Shah","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R34-7-20230208","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1681\/ASN.2006080894","article-title":"Physiology and pathophysiology of heme: Implications for kidney disease.","volume":"18","author":"Tracz","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R35-7-20230208","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0272-6386(12)80541-5","article-title":"Clinical profiles of gross hematuria in autosomal dominant polycystic kidney disease.","volume":"20","author":"Gabow","year":"1992","journal-title":"Am J Kidney Dis"},{"key":"R36-7-20230208","first-page":"161","article-title":"The influence of renal manifestations to the progression of autosomal dominant polycystic kidney disease.","volume":"13","author":"Idrizi","year":"2009","journal-title":"Hippokratia"},{"key":"R37-7-20230208","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1681\/ASN.V551178","article-title":"Pregnancy outcome and its relationship to progression of renal failure in autosomal dominant polycystic kidney disease.","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R38-7-20230208","first-page":"511","article-title":"Retrospective analysis of factors affecting the progression of chronic renal failure in adult polycystic kidney disease.","volume":"17","author":"Ahmed","year":"2006","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"R39-7-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2369-14-1","article-title":"Chronic asymptomatic pyuria precedes overt urinary tract infection and deterioration of renal function in autosomal dominant polycystic kidney disease.","volume":"14","author":"Hwang","year":"2013","journal-title":"BMC Nephrol"},{"key":"R40-7-20230208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.2008.558","article-title":"Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months.","volume":"75","author":"Kistler","year":"2009","journal-title":"Kidney Int"},{"key":"R41-7-20230208","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s004670050343","article-title":"Blood pressure and renal function in autosomal dominant polycystic kidney disease.","volume":"11","author":"Seeman","year":"1997","journal-title":"Pediatr Nephrol"},{"key":"R42-7-20230208","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00126097-200306000-00003","article-title":"Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease.","volume":"8","author":"Seeman","year":"2003","journal-title":"Blood Press Monit"},{"key":"R43-7-20230208","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1681\/ASN.V491654","article-title":"The spectrum of autosomal dominant polycystic kidney disease in children.","volume":"4","author":"Fick","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R44-7-20230208","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1111\/j.1523-1755.2005.00678.x","article-title":"Autosomal-dominant polycystic kidney disease in infancy and childhood: Progression and outcome.","volume":"68","author":"Shamshirsaz","year":"2005","journal-title":"Kidney Int"},{"key":"R45-7-20230208","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1038\/ki.1990.330","article-title":"Renal structure and hypertension in autosomal dominant polycystic kidney disease.","volume":"38","author":"Gabow","year":"1990","journal-title":"Kidney Int"},{"key":"R46-7-20230208","first-page":"155","article-title":"The phenotypic characteristics of adult polycystic kidney disease have greater impact on the course of progressive disease than the type of mutation of the polycystin 1 gene.","volume":"17","author":"Augustyniak-Bartosik","year":"2008","journal-title":"Adv Clin Exp Med"},{"key":"R47-7-20230208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1159\/000188846","article-title":"Influence of hypertension on early renal insufficiency in autosomal dominant polycystic kidney disease.","volume":"72","author":"Gonzalo","year":"1996","journal-title":"Nephron"},{"key":"R48-7-20230208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s10157-012-0706-3","article-title":"Clinical characteristics and predictors of progression of chronic kidney disease in autosomal dominant polycystic kidney disease: A single center experience.","volume":"17","author":"Ozkok","year":"2013","journal-title":"Clin Exp Nephrol"},{"key":"R49-7-20230208","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/01.ASN.0000018407.60002.B9","article-title":"Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: Results of a seven-year prospective randomized study.","volume":"13","author":"Schrier","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R50-7-20230208","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0272-6386(00)70195-8","article-title":"Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.","volume":"35","author":"Ecder","year":"2000","journal-title":"Am J Kidney Dis"},{"key":"R51-7-20230208","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ndt\/gfm731","article-title":"Renal and cardiac effects of antihypertensive treatment with ramipril vs metoprolol in autosomal dominant polycystic kidney disease.","volume":"23","author":"Zeltner","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R52-7-20230208","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/ki.2011.411","article-title":"Analysis of baseline parameters in the HALT polycystic kidney disease trials.","volume":"81","author":"Torres","year":"2012","journal-title":"Kidney Int"},{"key":"R53-7-20230208","doi-asserted-by":"crossref","first-page":"617904","DOI":"10.4061\/2011\/617904","article-title":"Acute kidney injury in ADPKD patients with pneumonia.","volume":"2011","author":"Franco Palacios","year":"2011","journal-title":"Int J Nephrol"},{"key":"R54-7-20230208","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1046\/j.1523-1755.2001.0590051654.x","article-title":"Progression of autosomal-dominant polycystic kidney disease in children.","volume":"59","author":"Fick-Brosnahan","year":"2001","journal-title":"Kidney Int"},{"key":"R55-7-20230208","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1053\/ajkd.2002.33379","article-title":"Relationship between renal volume growth and renal function in autosomal dominant polycystic kidney disease: A longitudinal study.","volume":"39","author":"Fick-Brosnahan","year":"2002","journal-title":"Am J Kidney Dis"},{"key":"R56-7-20230208","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1046\/j.1523-1755.2003.00185.x","article-title":"Renal structure in early autosomal-dominant polycystic kidney disease (ADPKD): The Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP) cohort.","volume":"64","author":"Chapman","year":"2003","journal-title":"Kidney Int"},{"key":"R57-7-20230208","doi-asserted-by":"crossref","first-page":"479","DOI":"10.2215\/CJN.09500911","article-title":"Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.","volume":"7","author":"Chapman","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"R58-7-20230208","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1046\/j.1523-1755.2003.00326.x","article-title":"Magnetic resonance measurements of renal blood flow as a marker of disease severity in autosomal-dominant polycystic kidney disease.","volume":"64","author":"King","year":"2003","journal-title":"Kidney Int"},{"key":"R59-7-20230208","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2215\/CJN.00910306","article-title":"Magnetic resonance measurements of renal blood flow and disease progression in autosomal dominant polycystic kidney disease.","volume":"2","author":"Torres","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"R60-7-20230208","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.2215\/CJN.00360110","article-title":"Early renal abnormalities in autosomal dominant polycystic kidney disease.","volume":"5","author":"Meijer","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R61-7-20230208","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1053\/j.ajkd.2005.05.029","article-title":"Earlier diagnosis of autosomal dominant polycystic kidney disease: Importance of family history and implications for cardiovascular and renal complications.","volume":"46","author":"Taylor","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R62-7-20230208","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1681\/ASN.V881292","article-title":"Left ventricular hypertrophy in autosomal dominant polycystic kidney disease.","volume":"8","author":"Chapman","year":"1997","journal-title":"J Am Soc Nephrol"},{"key":"R63-7-20230208","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1681\/ASN.V1051020","article-title":"Ambulatory blood pressure and left ventricular mass in normotensive patients with autosomal dominant polycystic kidney disease.","volume":"10","author":"Valero","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R64-7-20230208","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0272-6386(98)70071-X","article-title":"Left ventricular mass and diastolic function in normotensive young adults with autosomal dominant polycystic kidney disease.","volume":"32","author":"Bardaj\u00ed","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R65-7-20230208","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1053\/j.ajkd.2004.04.026","article-title":"Exercise blood pressure, cardiac structure, and diastolic function in young normotensive patients with polycystic kidney disease: A prehypertensive state.","volume":"44","author":"Martinez-Vea","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R66-7-20230208","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000013583","article-title":"Left ventricular hypertrophy in hypertensive patients with autosomal dominant polycystic kidney disease: Influence of blood pressure and humoral and neurohormonal factors.","volume":"20","author":"Martinez-Vea","year":"2000","journal-title":"Am J Nephrol"},{"key":"R67-7-20230208","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1681\/ASN.V381451","article-title":"Elevated blood pressure profile and left ventricular mass in children and young adults with autosomal dominant polycystic kidney disease.","volume":"3","author":"Zeier","year":"1993","journal-title":"J Am Soc Nephrol"},{"key":"R68-7-20230208","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1038\/ki.2008.397","article-title":"Increased left ventricular mass in children with autosomal dominant polycystic kidney disease and borderline hypertension.","volume":"74","author":"Cadnapaphornchai","year":"2008","journal-title":"Kidney Int"},{"key":"R69-7-20230208","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1681\/ASN.V5122032","article-title":"Cardiovascular abnormalities in children with autosomal dominant polycystic kidney disease.","volume":"5","author":"Ivy","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R70-7-20230208","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1053\/j.ajkd.2011.01.023","article-title":"Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: A population-based study.","volume":"57","author":"Patch","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"R71-7-20230208","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1046\/j.1523-1755.2003.00776.x","article-title":"Epidemiological study of kidney survival in autosomal dominant polycystic kidney disease.","volume":"63","author":"Schrier","year":"2003","journal-title":"Kidney Int"},{"key":"R72-7-20230208","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2215\/CJN.01460210","article-title":"Improved prognosis in patients with autosomal dominant polycystic kidney disease in Denmark.","volume":"5","author":"Orskov","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R73-7-20230208","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.2215\/CJN.04610511","article-title":"Cardiac magnetic resonance assessment of left ventricular mass in autosomal dominant polycystic kidney disease.","volume":"6","author":"Perrone","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R74-7-20230208","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1053\/ajkd.2001.27694","article-title":"Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease.","volume":"38","author":"Belz","year":"2001","journal-title":"Am J Kidney Dis"},{"key":"R75-7-20230208","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","article-title":"Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease.","volume":"43","author":"Kocaman","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R76-7-20230208","doi-asserted-by":"crossref","first-page":"c71","DOI":"10.1159\/000228537","article-title":"Cutaneous microcirculation is impaired in early autosomal dominant polycystic kidney disease.","volume":"113","author":"Ramunni","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"R77-7-20230208","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/ndt\/gfq806","article-title":"Peripheral augmentation index and vascular inflammation in autosomal dominant polycystic kidney disease.","volume":"26","author":"Heffernan","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"R78-7-20230208","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1681\/ASN.V5122037","article-title":"Dietary protein restriction, blood pressure control, and the progression of polycystic kidney disease.","volume":"5","author":"Klahr","year":"1995","journal-title":"J Am Soc Nephrol"},{"key":"R79-7-20230208","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1681\/ASN.V561349","article-title":"Overt proteinuria and microalbuminuria in autosomal dominant polycystic kidney disease.","volume":"5","author":"Chapman","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R80-7-20230208","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1373\/clinchem.2005.060038","article-title":"Assay for the measurement of copeptin, a stable peptide derived from the precursor of vasopressin.","volume":"52","author":"Morgenthaler","year":"2006","journal-title":"Clin Chem"},{"key":"R81-7-20230208","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.tem.2007.11.001","article-title":"Copeptin: Clinical use of a new biomarker.","volume":"19","author":"Morgenthaler","year":"2008","journal-title":"Trends Endocrinol Metab"},{"key":"R82-7-20230208","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2215\/CJN.04560510","article-title":"Copeptin, a surrogate marker of vasopressin, is associated with disease severity in autosomal dominant polycystic kidney disease.","volume":"6","author":"Meijer","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R83-7-20230208","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1053\/j.ajkd.2012.08.038","article-title":"Relationship of copeptin, a surrogate marker for arginine vasopressin, with change in total kidney volume and GFR decline in autosomal dominant polycystic kidney disease: Results from the CRISP cohort.","volume":"61","author":"Boertien","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R84-7-20230208","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1053\/j.ajkd.2010.06.023","article-title":"Association of urinary biomarkers with disease severity in patients with autosomal dominant polycystic kidney disease: A cross-sectional analysis.","volume":"56","author":"Meijer","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R85-7-20230208","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/ki.2010.355","article-title":"Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease.","volume":"79","author":"Reed","year":"2011","journal-title":"Kidney Int"},{"key":"R86-7-20230208","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2215\/CJN.03250410","article-title":"Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.","volume":"6","author":"Torres","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R87-7-20230208","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1093\/ndt\/gfs417","article-title":"Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.","volume":"28","author":"Helal","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R88-7-20230208","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000353730","article-title":"Serum uric acid levels and endothelial dysfunction in patients with autosomal dominant polycystic kidney disease.","volume":"123","author":"Kocyigit","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"R89-7-20230208","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","article-title":"Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease.","volume":"14","author":"Zheng","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R90-7-20230208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2215\/CJN.04140510","article-title":"Inflammation, oxidative stress, and insulin resistance in polycystic kidney disease.","volume":"6","author":"Menon","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R91-7-20230208","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ki.2010.375","article-title":"Patients with autosomal dominant polycystic kidney disease have elevated fibroblast growth factor 23 levels and a renal leak of phosphate.","volume":"79","author":"Pavik","year":"2011","journal-title":"Kidney Int"},{"key":"R92-7-20230208","doi-asserted-by":"crossref","first-page":"e53016","DOI":"10.1371\/journal.pone.0053016","article-title":"Urinary proteomic biomarkers for diagnosis and risk stratification of autosomal dominant polycystic kidney disease: A multicentric study.","volume":"8","author":"Kistler","year":"2013","journal-title":"PLoS ONE"},{"key":"R93-7-20230208","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ki.2011.465","article-title":"Evaluation of urine biomarkers of kidney injury in polycystic kidney disease.","volume":"81","author":"Parikh","year":"2012","journal-title":"Kidney Int"},{"key":"R94-7-20230208","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/nep.12045","article-title":"Role of interstitial inflammation in the pathogenesis of polycystic kidney disease.","volume":"18","author":"Ta","year":"2013","journal-title":"Nephrology (Carlton"},{"key":"R95-7-20230208","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1038\/ki.2011.459","article-title":"Low birth weight is associated with earlier onset of end-stage renal disease in Danish patients with autosomal dominant polycystic kidney disease.","volume":"81","author":"Orskov","year":"2012","journal-title":"Kidney Int"},{"key":"R96-7-20230208","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/01.ASN.0000025282.48298.7B","article-title":"The effect of caffeine on renal epithelial cells from patients with autosomal dominant polycystic kidney disease.","volume":"13","author":"Belibi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R97-7-20230208","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1590\/S0100-879X2012007500120","article-title":"Caffeine intake by patients with autosomal dominant polycystic kidney disease.","volume":"45","author":"Vendramini","year":"2012","journal-title":"Braz J Med Biol Res"},{"key":"R98-7-20230208","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1046\/j.1523-1755.1998.00067.x","article-title":"Smoking as a risk factor for end-stage renal failure in men with primary renal disease.","volume":"54","author":"Orth","year":"1998","journal-title":"Kidney Int"},{"key":"R99-7-20230208","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","article-title":"Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist.","volume":"9","author":"Gattone","year":"2003","journal-title":"Nat Med"},{"key":"R100-7-20230208","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm1004","article-title":"Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease.","volume":"10","author":"Torres","year":"2004","journal-title":"Nat Med"},{"key":"R101-7-20230208","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1681\/ASN.2006030251","article-title":"Increased water intake decreases progression of polycystic kidney disease in the PCK rat.","volume":"17","author":"Nagao","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R102-7-20230208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease.","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R103-7-20230208","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1681\/ASN.2007101100","article-title":"Therapy for polycystic kidney disease? It\u2019s water, stupid!","volume":"19","author":"Grantham","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R104-7-20230208","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.2215\/CJN.00790209","article-title":"A case for water in the treatment of polycystic kidney disease.","volume":"4","author":"Torres","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"R105-7-20230208","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/nrneph.2013.22","article-title":"Vasopressin: A novel target for the prevention and retardation of kidney disease?","volume":"9","author":"Bankir","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"R106-7-20230208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/ki.2013.23","article-title":"The medicinal use of water in renal disease.","volume":"84","author":"Wang","year":"2013","journal-title":"Kidney Int"},{"key":"R107-7-20230208","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2215\/CJN.03950510","article-title":"Water prescription in autosomal dominant polycystic kidney disease: A pilot study.","volume":"6","author":"Wang","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R108-7-20230208","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/hep.1840110619","article-title":"Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease.","volume":"11","author":"Gabow","year":"1990","journal-title":"Hepatology"},{"key":"R109-7-20230208","first-page":"1282","article-title":"Postmenopausal estrogen therapy selectively stimulates hepatic enlargement in women with autosomal dominant polycystic kidney disease.","volume":"26","author":"Sherstha","year":"1997","journal-title":"Hepatology"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201411000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:27:20Z","timestamp":1786130840000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201411000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013111184","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]}}}